HLA-DQA2 and Parkinson disease: Our PWAS results were supported by the PPMI differential protein levels analyses, in which GRN and HLA-DQA2 had increased protein levels in the PD prodromal stages and LRRK2+ cases compared to controls (Supplementary Fig. 4).